Details
Stereochemistry | ACHIRAL |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl
InChI
InChIKey=VEXZGXHMUGYJMC-UHFFFAOYSA-N
InChI=1S/ClH/h1H
HYDROCHLORIC ACID is formed by dissolving hydrogen chloride gas in water. It is a strong corrosive acid that is commonly used as a laboratory reagent. Also, it constitutes the majority of gastric acid, the human digestive fluid. Skin contact with HYDROCHLORIC ACID can cause redness, pain, and severe skin burns. It may cause severe burns to the eye and permanent eye damage.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Catabolism of haemoglobin-haptoglobin complexes in haemolytic uraemia-like syndromes of different etiologies. | 1982 Oct |
|
Aging impairs afferent nerve function in rat intestine. Reduction of mesenteric hyperemia induced by intraduodenal capsaicin and acid. | 1996 Feb |
|
Substance P may attenuate gastric hyperemia by a mast cell-dependent mechanism in the damaged gastric mucosa. | 1999 Nov |
|
Effect of vitamin E on aspirin-induced gastric mucosal injury in rats. | 2000 Mar |
|
The protease-activated receptor-2 agonist induces gastric mucus secretion and mucosal cytoprotection. | 2001 Jun |
|
Bile-induced adenosine triphosphate depletion and mucosal damage during reflux esophagitis. | 2001 May |
|
Tachykinins and airway microvascular leakage induced by HCl intra-oesophageal instillation. | 2002 Aug |
|
Protective role of vanilloid receptor type 1 in HCl-induced gastric mucosal lesions in rats. | 2004 Apr |
|
Expression of a 72-kDa heat shock protein, and its cytoprotective function, in gastric mucosa in cirrhotic rats. | 2004 Aug |
|
The effects of aspirin on gastric mucosal integrity, surface hydrophobicity, and prostaglandin metabolism in cyclooxygenase knockout mice. | 2004 Jul |
|
Effects of celecoxib on acid-challenged gastric mucosa of rats: comparison with metamizol and piroxicam. | 2004 Jun |
|
Jejunal afferent nerve sensitivity in wild-type and TRPV1 knockout mice. | 2004 Nov 1 |
|
Pulmonary aspiration: new therapeutic approaches in the experimental model. | 2005 Sep |
|
Renal expression of the ammonia transporters, Rhbg and Rhcg, in response to chronic metabolic acidosis. | 2006 Feb |
|
Genetic evidence for a protective role of heat shock factor 1 against irritant-induced gastric lesions. | 2007 Apr |
|
Effect of prone position without PEEP on oxygenation and complacency in an experimental model. | 2007 Jul-Aug |
|
Spontaneous hypersensitivity in mesenteric afferent nerves of mice deficient in the sst2 subtype of somatostatin receptor. | 2007 Jun 1 |
|
Beneficial effects of suplatast tosilate (IPD-1151T) in a rat cystitis model induced by intravesical hydrochloric acid. | 2007 Oct |
|
Bladder afferent sensitivity in wild-type and TRPV1 knockout mice. | 2007 Sep 1 |
|
Muscarinic receptors involved in airway vascular leakage induced by experimental gastro-oesophageal reflux. | 2008 Apr 23 |
|
Lung injury and recovery in a murine model of unilateral acid aspiration: functional, biochemical, and morphologic characterization. | 2008 Jun |
|
Lactic acid increases aquaporin 4 expression on the cell membrane of cultured rat astrocytes. | 2008 May |
|
Permissive hypercapnia, instituted via reduction of pressure amplitude on pulmonary tissue protection during high frequency oscillatory ventilation, is not protective in a rat model of acid-induced lung injury. | 2009 Aug |
|
Gastroprotective activity of alkaloid extract and 2-phenylquinoline obtained from the bark of Galipea longiflora Krause (Rutaceae). | 2009 Jul 15 |
|
Influence of intra-oesophageal capsaicin instillation on heartburn induction and oesophageal sensitivity in man. | 2009 Oct |
|
Proton acts as a neurotransmitter for nicotine-induced adrenergic and calcitonin gene-related peptide-containing nerve-mediated vasodilation in the rat mesenteric artery. | 2009 Sep |
|
Role of the Rhesus glycoprotein, Rh B glycoprotein, in renal ammonia excretion. | 2010 Nov |
|
Loss of muscarinic and purinergic receptors in urinary bladder of rats with hydrochloric acid-induced cystitis. | 2010 Oct |
|
Chemicals inducing acute irritant contact dermatitis mobilize intracellular calcium in human keratinocytes. | 2013 Feb |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EPA PESTICIDE CODE |
45901
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
||
|
WHO-VATC |
QB05XA13
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
||
|
WHO-VATC |
QA09AB03
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
||
|
DSLD |
1445 (Number of products:1)
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
||
|
JECFA EVALUATION |
INS-507
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
||
|
WHO-ATC |
A09AB03
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
||
|
WHO-ATC |
B05XA13
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
||
|
CODEX ALIMENTARIUS (GSFA) |
INS-507
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
||
|
FDA ORPHAN DRUG |
98896
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB50009
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
PRIMARY | |||
|
C45678
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
CONCEPT | Industrial Aid | ||
|
HYDROCHLORIC ACID
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
PRIMARY | Description: A clear, colourless, fuming liquid; odour, pungent. Miscibility: Miscible with water. Category: Acidifying agent. Storage: Hydrochloric acid should be kept in a tightly closed container. Additional information: The fumes and odour disappear when the acid is diluted with 2 volumes of water. Mass density: .RHO.20 = about 1.18 g/mL. Requirement: Hydrochloric acid contains not less than 35.0% m/mand not more than the equivalent of 38.0% m/mof HCl. | ||
|
4568
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
PRIMARY | |||
|
5486
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
PRIMARY | RxNorm | ||
|
HYDROCHLORIC ACID
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
PRIMARY | |||
|
C76716
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
PRIMARY | |||
|
SUB129759
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
ALTERNATIVE | |||
|
313
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
PRIMARY | |||
|
7647-01-0
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
PRIMARY | |||
|
17883
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
PRIMARY | |||
|
m6101
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID2020711
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
PRIMARY | |||
|
QTT17582CB
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
PRIMARY | |||
|
CHEMBL1231821
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
PRIMARY | |||
|
231-595-7
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
PRIMARY | |||
|
m6088
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
PRIMARY | Merck Index | ||
|
D006851
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
PRIMARY | |||
|
SUB12513MIG
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
PRIMARY | |||
|
QTT17582CB
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
PRIMARY | |||
|
DB13366
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
PRIMARY | |||
|
77365
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
PRIMARY | |||
|
100000078724
Created by
admin on Mon Mar 31 18:06:52 GMT 2025 , Edited by admin on Mon Mar 31 18:06:52 GMT 2025
|
PRIMARY |
ACTIVE MOIETY